New imaging tool may help detect Eye-Area skin cancer without a biopsy
NCT ID NCT06279143
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tested a non-invasive imaging device called dermal optical coherence tomography (D-OCT) to diagnose basal cell carcinoma (a common skin cancer) around the eye area. Researchers compared its accuracy to standard biopsy results in 210 adults with suspected lesions. The goal was to see if D-OCT could reliably detect and classify these cancers without needing a tissue sample.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BCC are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Department of Ophthalmology, University Hospital of Southern Denmark, Vejle Hospital
Vejle, Region of Southern Danmark, 7100, Denmark
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Could your daily commute be drying out your skin?
- Skip the clinic: could a smartphone survey replace your post-surgery eye check?
- Gene therapy gel targets rare blistering skin disease
- Needle-Free light therapy shows promise for common skin cancer
- Scientists probe UV's hidden immune trick in skin
- AI reads your symptom stories to find hidden medical clues